Blood neurofilament light: a critical review of its application to neurologic disease

Neuronal injury is a universal event that occurs in disease processes that affect both the central and peripheral nervous systems. A blood biomarker linked to neuronal injury would provide a critical measure to understand and treat neurologic diseases. Neurofilament light chain (NfL), a cytoskeletal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of clinical and translational neurology Jg. 7; H. 12; S. 2508 - 2523
Hauptverfasser: Barro, Christian, Chitnis, Tanuja, Weiner, Howard L.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States John Wiley & Sons, Inc 01.12.2020
John Wiley and Sons Inc
Schlagworte:
Antibodies
Biomarkers
Blood
Brain research
Disease
Gene expression
Nervous system
Neurological disorders
Physiology
Plasma
Review
Reviews
United States > US
ISSN:2328-9503, 2328-9503
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Neuronal injury is a universal event that occurs in disease processes that affect both the central and peripheral nervous systems. A blood biomarker linked to neuronal injury would provide a critical measure to understand and treat neurologic diseases. Neurofilament light chain (NfL), a cytoskeletal protein expressed only in neurons, has emerged as such a biomarker. With the ability to quantify neuronal damage in blood, NfL is being applied to a wide range of neurologic conditions to investigate and monitor disease including assessment of treatment efficacy. Blood NfL is not specific for one disease and its release can also be induced by physiological processes. Longitudinal studies in multiple sclerosis, traumatic brain injury, and stroke show accumulation of NfL over days followed by elevated levels over months. Therefore, it may be hard to determine with a single measurement when the peak of NfL is reached and when the levels are normalized. Nonetheless, measurement of blood NfL provides a new blood biomarker for neurologic diseases overcoming the invasiveness of CSF sampling that restricted NfL clinical application. In this review, we examine the use of blood NfL as a biologic test for neurologic disease.
AbstractList Neuronal injury is a universal event that occurs in disease processes that affect both the central and peripheral nervous systems. A blood biomarker linked to neuronal injury would provide a critical measure to understand and treat neurologic diseases. Neurofilament light chain (NfL), a cytoskeletal protein expressed only in neurons, has emerged as such a biomarker. With the ability to quantify neuronal damage in blood, NfL is being applied to a wide range of neurologic conditions to investigate and monitor disease including assessment of treatment efficacy. Blood NfL is not specific for one disease and its release can also be induced by physiological processes. Longitudinal studies in multiple sclerosis, traumatic brain injury, and stroke show accumulation of NfL over days followed by elevated levels over months. Therefore, it may be hard to determine with a single measurement when the peak of NfL is reached and when the levels are normalized. Nonetheless, measurement of blood NfL provides a new blood biomarker for neurologic diseases overcoming the invasiveness of CSF sampling that restricted NfL clinical application. In this review, we examine the use of blood NfL as a biologic test for neurologic disease.Neuronal injury is a universal event that occurs in disease processes that affect both the central and peripheral nervous systems. A blood biomarker linked to neuronal injury would provide a critical measure to understand and treat neurologic diseases. Neurofilament light chain (NfL), a cytoskeletal protein expressed only in neurons, has emerged as such a biomarker. With the ability to quantify neuronal damage in blood, NfL is being applied to a wide range of neurologic conditions to investigate and monitor disease including assessment of treatment efficacy. Blood NfL is not specific for one disease and its release can also be induced by physiological processes. Longitudinal studies in multiple sclerosis, traumatic brain injury, and stroke show accumulation of NfL over days followed by elevated levels over months. Therefore, it may be hard to determine with a single measurement when the peak of NfL is reached and when the levels are normalized. Nonetheless, measurement of blood NfL provides a new blood biomarker for neurologic diseases overcoming the invasiveness of CSF sampling that restricted NfL clinical application. In this review, we examine the use of blood NfL as a biologic test for neurologic disease.
Neuronal injury is a universal event that occurs in disease processes that affect both the central and peripheral nervous systems. A blood biomarker linked to neuronal injury would provide a critical measure to understand and treat neurologic diseases. Neurofilament light chain (NfL), a cytoskeletal protein expressed only in neurons, has emerged as such a biomarker. With the ability to quantify neuronal damage in blood, NfL is being applied to a wide range of neurologic conditions to investigate and monitor disease including assessment of treatment efficacy. Blood NfL is not specific for one disease and its release can also be induced by physiological processes. Longitudinal studies in multiple sclerosis, traumatic brain injury, and stroke show accumulation of NfL over days followed by elevated levels over months. Therefore, it may be hard to determine with a single measurement when the peak of NfL is reached and when the levels are normalized. Nonetheless, measurement of blood NfL provides a new blood biomarker for neurologic diseases overcoming the invasiveness of CSF sampling that restricted NfL clinical application. In this review, we examine the use of blood NfL as a biologic test for neurologic disease.
Author Barro, Christian
Chitnis, Tanuja
Weiner, Howard L.
AuthorAffiliation 1 Ann Romney Center for Neurologic Diseases Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
AuthorAffiliation_xml – name: 1 Ann Romney Center for Neurologic Diseases Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
Author_xml – sequence: 1
  givenname: Christian
  orcidid: 0000-0002-7795-7383
  surname: Barro
  fullname: Barro, Christian
  email: cbarro1@bwh.harvard.edu
  organization: Harvard Medical School
– sequence: 2
  givenname: Tanuja
  orcidid: 0000-0002-9897-4422
  surname: Chitnis
  fullname: Chitnis, Tanuja
  organization: Harvard Medical School
– sequence: 3
  givenname: Howard L.
  orcidid: 0000-0003-0203-9681
  surname: Weiner
  fullname: Weiner, Howard L.
  email: hweiner@rics.bwh.harvard.edu
  organization: Harvard Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33146954$$D View this record in MEDLINE/PubMed
BookMark eNp9kV9vFCEUxYmpsbX2xQ9gSHwxJluBywyLDyZ147-k0Rf7TO4ysKVhYYWZNv320k5ramN84gZ-5-Rwz3Oyl3JyhLzk7JgzJt6hTXDccQHyCTkQIJYL3THYezDvk6NaLxhjnIsOlHhG9gG47HUnD8jZx5jzQJObSvYh4talkcawOR_fU6S2hDFYjLS4y-CuaPY0jJXibhfb9RhyomOexTFvgqVDqA6re0GeeozVHd2dh-Ts86efq6-L0x9fvq1OThe241IuEAdYqrXkS5BSCq9tm5wYhAbVcd8PvEfuNXjOtODdGpXm3Ir10INHqxAOyYfZdzett26wLXzBaHYlbLFcm4zB_P2SwrnZ5EujFAghoRm8uTMo-dfk6mi2oVoXIyaXp2qE7FSvtNasoa8foRd5Kql9r1G9lqrvQTfq1cNEf6Lcb7wBbAZsybUW540N4-0qW8AQDWfmpldz06u57bVJ3j6S3Lv-E-YzfBWiu_4PaU5W32HW_AbfxrHH
CitedBy_id crossref_primary_10_1016_j_ebiom_2023_104456
crossref_primary_10_1016_j_msard_2022_104177
crossref_primary_10_1016_j_msard_2022_104176
crossref_primary_10_3390_brainsci14121296
crossref_primary_10_1212_NXI_0000000000001102
crossref_primary_10_1016_j_msard_2022_103885
crossref_primary_10_1007_s11357_023_00888_1
crossref_primary_10_1016_j_jneumeth_2021_109281
crossref_primary_10_3390_nu14235102
crossref_primary_10_1111_jnc_15891
crossref_primary_10_1016_j_brainres_2023_148587
crossref_primary_10_3389_fneur_2021_791065
crossref_primary_10_1016_j_neurobiolaging_2024_05_016
crossref_primary_10_1038_s41531_023_00605_x
crossref_primary_10_3389_fnagi_2022_887498
crossref_primary_10_1016_j_arr_2024_102257
crossref_primary_10_1007_s00415_023_11737_8
crossref_primary_10_1097_QAD_0000000000003675
crossref_primary_10_1016_j_ebiom_2024_104970
crossref_primary_10_3389_fnins_2022_819010
crossref_primary_10_1002_acn3_51996
crossref_primary_10_1016_j_neubiorev_2023_105035
crossref_primary_10_3390_cancers16152680
crossref_primary_10_1177_0271678X21992664
crossref_primary_10_1177_03331024251338178
crossref_primary_10_1038_s41380_025_03126_6
crossref_primary_10_1016_j_nbd_2025_106954
crossref_primary_10_1212_NXI_0000000000001051
crossref_primary_10_1002_brb3_2873
crossref_primary_10_1182_bloodadvances_2022008119
crossref_primary_10_3390_molecules26113423
crossref_primary_10_1007_s40520_021_02054_z
crossref_primary_10_1007_s11357_025_01567_z
crossref_primary_10_3390_medicina60091401
crossref_primary_10_1016_j_ncl_2024_12_005
crossref_primary_10_1002_bcp_70253
crossref_primary_10_1016_S1773_035X_21_00193_3
crossref_primary_10_1161_JAHA_122_025910
crossref_primary_10_3390_brainsci14030272
crossref_primary_10_7759_cureus_85152
crossref_primary_10_1016_j_msard_2021_103090
crossref_primary_10_3390_biomedicines12071539
crossref_primary_10_3390_brainsci12111521
crossref_primary_10_1002_acn3_51524
crossref_primary_10_3390_ijms24076628
crossref_primary_10_1038_s41380_024_02524_6
crossref_primary_10_1002_bsa3_70022
crossref_primary_10_1038_s41598_022_12287_1
crossref_primary_10_3389_fimmu_2021_669811
crossref_primary_10_1111_ene_16369
crossref_primary_10_1177_17562864251314011
crossref_primary_10_3390_jcm10215085
crossref_primary_10_5507_bp_2024_032
crossref_primary_10_33590_emjneurol_AICD3968
crossref_primary_10_3389_fnins_2021_648743
crossref_primary_10_3390_brainsci14030269
crossref_primary_10_1177_09612033241272961
crossref_primary_10_1177_13872877251320123
crossref_primary_10_1016_j_clim_2023_109688
crossref_primary_10_1002_ijgo_70421
crossref_primary_10_1016_j_msard_2025_106410
crossref_primary_10_3389_fimmu_2025_1548897
crossref_primary_10_1093_brain_awab241
crossref_primary_10_1007_s00414_023_02990_7
crossref_primary_10_1007_s11064_024_04244_3
crossref_primary_10_1093_jalm_jfae099
crossref_primary_10_1177_13524585211047977
crossref_primary_10_1016_j_ensci_2025_100550
crossref_primary_10_3389_fneur_2023_1145737
crossref_primary_10_1212_WNL_0000000000201158
crossref_primary_10_3389_fnagi_2021_759182
crossref_primary_10_1186_s13098_023_01023_y
crossref_primary_10_1136_bmjno_2024_000788
crossref_primary_10_1016_j_jneuroim_2024_578289
crossref_primary_10_1212_WNL_0000000000200903
crossref_primary_10_1016_j_cell_2025_06_038
crossref_primary_10_3390_cimb46050262
crossref_primary_10_3390_diagnostics14212408
crossref_primary_10_1038_s41582_024_00955_x
crossref_primary_10_1212_WNL_0000000000013229
crossref_primary_10_1515_cclm_2023_0518
crossref_primary_10_1002_jimd_70032
crossref_primary_10_1186_s40478_025_02109_6
crossref_primary_10_1212_NXI_0000000000200052
crossref_primary_10_1080_20450907_2024_2386233
crossref_primary_10_1186_s43162_025_00476_z
crossref_primary_10_1093_brain_awac328
crossref_primary_10_1016_j_cca_2022_08_017
crossref_primary_10_3389_fnagi_2022_921809
crossref_primary_10_3389_fneur_2023_1096358
crossref_primary_10_1007_s40520_023_02521_9
crossref_primary_10_1111_ene_15858
crossref_primary_10_1007_s40263_024_01132_w
crossref_primary_10_1177_13872877251352103
crossref_primary_10_1016_j_msard_2023_104893
crossref_primary_10_3390_app15189952
crossref_primary_10_1016_j_jpsychires_2021_05_072
crossref_primary_10_3389_fneur_2024_1382468
crossref_primary_10_1038_s41380_024_02774_4
crossref_primary_10_1002_acn3_51542
crossref_primary_10_1016_j_cca_2024_120118
crossref_primary_10_1016_j_chstcc_2025_100159
crossref_primary_10_3389_fneur_2021_754518
crossref_primary_10_3390_ijms25115676
crossref_primary_10_1186_s40001_023_01375_1
crossref_primary_10_23736_S1825_859X_24_00256_1
crossref_primary_10_1080_02699052_2022_2037711
crossref_primary_10_3390_nu17162588
crossref_primary_10_1002_ana_27222
crossref_primary_10_1177_13872877251340999
crossref_primary_10_1080_1354750X_2023_2172211
crossref_primary_10_1097_YCO_0000000000000979
crossref_primary_10_1016_j_nmd_2023_05_010
crossref_primary_10_1177_02841851241305738
crossref_primary_10_1080_09297049_2023_2273573
crossref_primary_10_3390_diagnostics13213330
crossref_primary_10_3390_ijms23179639
crossref_primary_10_1177_1352458521993066
crossref_primary_10_3389_fonc_2022_942960
crossref_primary_10_1016_j_arr_2024_102566
crossref_primary_10_1212_CON_0000000000001168
crossref_primary_10_1016_j_ecoenv_2022_114423
crossref_primary_10_3390_cells11162480
crossref_primary_10_1007_s00415_025_13292_w
crossref_primary_10_1016_j_cca_2024_119817
crossref_primary_10_1038_s41531_025_00951_y
crossref_primary_10_1055_s_0043_1775764
crossref_primary_10_3390_ijms24054375
crossref_primary_10_3389_fnins_2023_1237284
crossref_primary_10_3389_fnins_2021_654942
crossref_primary_10_1111_ane_13415
crossref_primary_10_1212_WNL_0000000000200257
crossref_primary_10_1111_cts_70176
crossref_primary_10_3390_cells10061537
crossref_primary_10_1016_j_neurot_2025_e00591
crossref_primary_10_1016_j_jns_2024_123137
crossref_primary_10_1186_s12889_024_17811_8
crossref_primary_10_1002_jum_16393
crossref_primary_10_3390_ijms251910761
crossref_primary_10_26508_lsa_202402571
crossref_primary_10_1016_j_biopha_2023_115535
crossref_primary_10_3390_ijms241411624
crossref_primary_10_1186_s12974_021_02138_7
crossref_primary_10_3390_cells13060511
crossref_primary_10_1016_j_resuscitation_2025_110698
crossref_primary_10_1212_NXI_0000000000200003
crossref_primary_10_1093_arclin_acae096
crossref_primary_10_1177_00048674211058684
crossref_primary_10_3390_jcm11092430
crossref_primary_10_3390_neurolint17040056
crossref_primary_10_31083_j_jin2204085
crossref_primary_10_1080_0886022X_2024_2391955
crossref_primary_10_3389_fneur_2022_1011470
crossref_primary_10_1016_j_neurot_2025_e00588
crossref_primary_10_1177_13524585251360972
crossref_primary_10_3389_fneur_2022_935382
crossref_primary_10_1177_13524585221137697
crossref_primary_10_1038_s41598_024_77446_y
crossref_primary_10_1007_s12035_023_03327_6
crossref_primary_10_1038_s41390_021_01649_6
crossref_primary_10_3389_fnagi_2025_1547394
crossref_primary_10_1177_13524585231198760
crossref_primary_10_1016_j_hrthm_2024_08_048
crossref_primary_10_1111_ene_15762
crossref_primary_10_1186_s13567_024_01441_4
crossref_primary_10_3389_fneur_2024_1384678
crossref_primary_10_3390_ijms241612751
crossref_primary_10_1016_j_jagp_2024_03_008
crossref_primary_10_3389_fcell_2022_1062807
crossref_primary_10_1136_jnnp_2022_329020
crossref_primary_10_3390_bioengineering9110612
crossref_primary_10_1038_s42003_024_06804_3
crossref_primary_10_1016_j_neuroscience_2024_05_017
crossref_primary_10_1002_alz_70554
crossref_primary_10_1016_j_jad_2025_01_045
crossref_primary_10_1002_ana_26265
crossref_primary_10_1016_j_arr_2023_102044
crossref_primary_10_1097_YCO_0000000000000756
crossref_primary_10_1016_j_soncn_2025_151944
crossref_primary_10_1089_neu_2024_0039
crossref_primary_10_3389_fpsyt_2023_1176266
Cites_doi 10.1136/annrheumdis-2017-212045
10.1016/j.dadm.2018.06.001
10.1212/WNL.0000000000003154
10.1002/acn3.795
10.5853/jos.2017.02565
10.1016/0022-510X(94)90298-4
10.1007/s00415-019-09567-8
10.1007/s00415-019-09477-9
10.1101/cshperspect.a018309
10.1212/WNL.0000000000007179
10.1212/WNL.0000000000002474
10.1212/WNL.0000000000009097
10.1183/09031936.00059814
10.1016/j.beem.2013.05.011
10.1016/0197-4580(94)90049-3
10.1177/1352458520912379
10.1212/WNL.0000000000003912
10.1212/WNL.0000000000009371
10.1002/acn3.678
10.1136/bmjsem-2018-000433
10.1212/NXI.0000000000000749
10.1111/jns.12319
10.1111/nan.12511
10.1111/jnc.14542
10.1002/ana.24954
10.1002/acn3.50972
10.1080/21678421.2019.1646769
10.1056/NEJM199807303390501
10.1001/jamaneurol.2019.2137
10.1212/WNL.0000000000007032
10.1016/S1474-4422(20)30137-X
10.1016/S1474-4422(20)30071-5
10.1186/s40478-018-0649-3
10.1212/WNL.0000000000004761
10.1136/jnnp-2017-316605
10.1161/CIRCULATIONAHA.114.009029
10.1212/WNL.0000000000006902
10.1038/s41591-018-0304-3
10.1212/WNL.0000000000007767
10.1186/s13195-018-0439-y
10.1136/jnnp-2018-319190
10.1212/WNL.90.15_supplement.S8.006
10.1001/jamaneurol.2019.1534
10.1212/NXI.0000000000000714
10.1089/neu.2017.5553
10.1212/WNL.0000000000005518
10.1001/jamaneurol.2020.1087
10.1089/15368590252917647
10.1212/WNL.0000000000003653
10.1038/nrdp.2017.71
10.1016/j.parkreldis.2020.04.009
10.1016/j.ebiom.2015.11.036
10.1038/s41582-018-0058-z
10.1177/1352458513482374
10.1212/WNL.0000000000003680
10.1038/s41598-018-35766-w
10.1038/srep36791
10.1038/nrdp.2015.56
10.1038/s41572-019-0118-8
10.1080/21678421.2020.1779300
10.1212/WNL.0000000000006282
10.1111/ene.14063
10.1038/nrdp.2017.13
10.1080/00365513.2020.1730434
10.1016/j.jstrokecerebrovasdis.2019.05.008
10.1002/acn3.51158
10.1177/1352458519868081
10.1161/STROKEAHA.119.024941
10.1002/ana.25885
10.1186/s13195-019-0472-5
10.1212/WNL.0000000000004029
10.1001/archneur.62.6.865
10.1371/journal.pone.0075091
10.1177/1352458519885613
10.1038/nrneurol.2012.241
10.1046/j.1471-4159.1996.67052013.x
10.1212/WNL.0000000000004932
10.1212/WNL.0000000000009559
10.1016/j.jpsychires.2019.03.019
10.1177/2211068215589580
10.1016/S0140-6736(15)00461-4
10.1002/ana.24552
10.1016/S1474-4422(17)30124-2
10.1016/j.ebiom.2020.102807
10.1056/NEJMoa2003715
10.1016/j.neurobiolaging.2017.06.002
10.1212/WNL.0000000000004645
10.1515/cclm-2019-0015
10.1093/brain/awaa098
10.1212/WNL.0000000000009571
10.1016/S1474-4422(19)30354-0
10.1093/hmg/3.10.1757
10.1136/jnnp-2018-318704
10.3233/JAD-170773
10.1111/ene.13554
10.1515/cclm-2015-1195
10.1089/neu.2015.4295
10.1002/ana.25276
10.1001/jamaneurol.2019.3238
10.1002/acn3.325
10.1038/s41398-019-0518-2
10.1177/1352458518765666
10.1161/STROKEAHA.119.026410
10.1212/WNL.0000000000004683
10.1080/02699052.2019.1565895
10.1212/WNL.0000000000008057
10.1002/mds.27897
10.1016/S1474-4422(17)30470-2
10.1002/acn3.50872
10.1111/ene.13965
10.1212/NXI.0000000000000422
10.1002/acn3.638
10.1212/WNL.0000000000006318
10.1093/jnen/59.11.972
10.1016/j.brainres.2017.05.011
10.1186/s13195-018-0404-9
10.1212/WNL.0000000000004667
10.1161/HYPERTENSIONAHA.117.10314
10.1038/s41467-020-14612-6
10.1186/s12884-019-2570-6
10.1093/eurheartj/ehy565.P2908
10.1093/brain/awy154
10.1038/nrneurol.2017.188
10.1097/MD.0000000000001908
10.1001/jamaneurol.2016.6117
10.1186/s12974-018-1249-7
10.1007/s00415-019-09547-y
10.1002/acn3.51060
10.1177/1352458519869496
10.1177/1756286419846058
10.1212/WNL.0000000000001642
10.1177/1352458517715132
10.3389/fneur.2015.00179
10.1038/nrdp.2016.84
ContentType Journal Article
Copyright 2020 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association
2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association
– notice: 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
– notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1002/acn3.51234
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Psychology Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Publicly Available Content Database
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Blood NfL: A Critical Review of Its Application
EISSN 2328-9503
EndPage 2523
ExternalDocumentID PMC7732243
33146954
10_1002_acn3_51234
ACN351234
Genre reviewArticle
Research Support, U.S. Gov't, Non-P.H.S
Review
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: Swiss National Science Foundation
  funderid: P400PM_191077
– fundername: Nancy Davis Center Without Walls
– fundername: National MS Society SUMMIT Consortium
– fundername: U.S. Department of Defense
  funderid: W81XWH‐18‐1‐0648
– fundername: ;
  grantid: W81XWH‐18‐1‐0648
– fundername: ;
  grantid: P400PM_191077
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8FI
8FJ
AAHHS
ABDBF
ABUWG
ACCFJ
ACCMX
ACGFS
ACUHS
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
ADZOD
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
DWQXO
EBS
EJD
FYUFA
GNUQQ
GODZA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
INH
ITC
KQ8
M2M
M48
OK1
PIMPY
PQQKQ
PROAC
PSYQQ
RPM
SUPJJ
UKHRP
WIN
AAMMB
AAYXX
AEFGJ
AFFHD
AGXDD
AIDQK
AIDYY
CITATION
PHGZM
PHGZT
NPM
3V.
7XB
8FK
K9.
M~E
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c5144-aad387b41834442f9c183e2d293751f6d16a1f93f109215ba7911c2bd63fac7a3
IEDL.DBID 24P
ISICitedReferencesCount 200
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000584729800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2328-9503
IngestDate Tue Nov 04 02:01:38 EST 2025
Fri Sep 05 14:20:28 EDT 2025
Tue Oct 07 06:23:43 EDT 2025
Wed Feb 19 02:28:24 EST 2025
Tue Nov 18 22:22:35 EST 2025
Sat Nov 29 02:47:05 EST 2025
Wed Jan 22 16:31:06 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License Attribution-NonCommercial-NoDerivs
2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5144-aad387b41834442f9c183e2d293751f6d16a1f93f109215ba7911c2bd63fac7a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Funding InformationCB is supported by a postdoctoral fellowship from the Swiss National Science Foundation (P400PM_191077). This study was funded in part by the U.S. Department of Defense (W81XWH‐18‐1‐0648 to TC), the National MS Society SUMMIT Consortium, and the Nancy Davis Center Without Walls.
ORCID 0000-0003-0203-9681
0000-0002-7795-7383
0000-0002-9897-4422
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Facn3.51234
PMID 33146954
PQID 2469476639
PQPubID 2034580
PageCount 16
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7732243
proquest_miscellaneous_2457679990
proquest_journals_2469476639
pubmed_primary_33146954
crossref_citationtrail_10_1002_acn3_51234
crossref_primary_10_1002_acn3_51234
wiley_primary_10_1002_acn3_51234_ACN351234
PublicationCentury 2000
PublicationDate December 2020
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: December 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bognor Regis
– name: Hoboken
PublicationTitle Annals of clinical and translational neurology
PublicationTitleAlternate Ann Clin Transl Neurol
PublicationYear 2020
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2019; 90
2013; 3
2019; 93
2019; 92
2017; 81
2019; 11
2017; 88
2015; 386
2019; 12
2017; 89
2005; 62
2019; 19
2019; 18
2017; 1668
2020; 11
2013; 8
2014; 130
2020; 19
2013; 9
2016; 33
2018; 39
2017; 74
2018; 8
2018; 5
2018; 4
2019; 20
2015; 84
2020; 95
2020; 94
2019; 24
2019; 26
2019; 25
2019; 28
2020; 88
1996; 67
2018; 35
2019; 7
2019; 9
2019; 6
2019; 5
2020; 383
2019; 33
2020; 143
2020; 35
2020; 267
2018; 20
2014; 44
2018; 25
2018; 24
2016; 6
2018; 17
2016; 2
2016; 3
2017; 58
2019; 45
2016; 21
2018; 91
2020; 27
2018; 90
1994; 15
2018; 10
2018; 15
2018; 14
2017; 3
2013; 27
2019; 50
2019; 57
2020; 56
2018; 84
2018; 89
2017; 9
2016; 79
2013; 19
2020; 7
2020; 2
2000; 59
2016; 87
2016; 86
2019; 113
2018; 71
2018; 77
2018; 141
2015; 1
2015; 6
2019; 76
2015; 94
2018; 146
2020; 80
2016; 54
1998; 339
2018; 62
2020; 77
2019; 266
1994; 122
2020; 74
2020
2017; 16
2002; 21
1994; 3
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_40_1
e_1_2_10_109_1
e_1_2_10_131_1
e_1_2_10_70_1
e_1_2_10_93_1
e_1_2_10_2_1
e_1_2_10_139_1
e_1_2_10_18_1
e_1_2_10_74_1
e_1_2_10_97_1
Kuhle J (e_1_2_10_81_1) 2018; 90
e_1_2_10_116_1
e_1_2_10_6_1
e_1_2_10_55_1
e_1_2_10_135_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_78_1
e_1_2_10_112_1
e_1_2_10_13_1
e_1_2_10_32_1
e_1_2_10_51_1
e_1_2_10_120_1
e_1_2_10_82_1
e_1_2_10_128_1
e_1_2_10_29_1
e_1_2_10_63_1
e_1_2_10_86_1
e_1_2_10_105_1
e_1_2_10_124_1
e_1_2_10_25_1
e_1_2_10_48_1
e_1_2_10_67_1
e_1_2_10_101_1
e_1_2_10_45_1
e_1_2_10_22_1
Kuhle J (e_1_2_10_36_1) 2018; 24
e_1_2_10_41_1
Traxinger K (e_1_2_10_54_1) 2013; 3
e_1_2_10_132_1
e_1_2_10_90_1
e_1_2_10_71_1
e_1_2_10_117_1
e_1_2_10_94_1
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_75_1
e_1_2_10_113_1
e_1_2_10_136_1
e_1_2_10_38_1
e_1_2_10_98_1
e_1_2_10_56_1
e_1_2_10_79_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_121_1
e_1_2_10_60_1
e_1_2_10_129_1
e_1_2_10_83_1
e_1_2_10_64_1
e_1_2_10_102_1
e_1_2_10_125_1
e_1_2_10_140_1
e_1_2_10_49_1
e_1_2_10_87_1
e_1_2_10_26_1
e_1_2_10_68_1
e_1_2_10_23_1
Sejbaek T (e_1_2_10_27_1) 2019; 90
e_1_2_10_46_1
e_1_2_10_69_1
e_1_2_10_42_1
Sharma A (e_1_2_10_35_1) 2018; 24
e_1_2_10_110_1
e_1_2_10_91_1
e_1_2_10_72_1
e_1_2_10_95_1
e_1_2_10_118_1
e_1_2_10_4_1
e_1_2_10_53_1
e_1_2_10_137_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_76_1
e_1_2_10_99_1
e_1_2_10_114_1
e_1_2_10_8_1
e_1_2_10_57_1
e_1_2_10_133_1
e_1_2_10_58_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_30_1
e_1_2_10_119_1
e_1_2_10_80_1
e_1_2_10_61_1
e_1_2_10_84_1
Turner MR (e_1_2_10_106_1) 2016; 87
e_1_2_10_107_1
e_1_2_10_126_1
e_1_2_10_65_1
e_1_2_10_88_1
e_1_2_10_103_1
e_1_2_10_122_1
e_1_2_10_24_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_108_1
e_1_2_10_130_1
e_1_2_10_92_1
e_1_2_10_73_1
e_1_2_10_115_1
e_1_2_10_138_1
e_1_2_10_96_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_77_1
e_1_2_10_111_1
e_1_2_10_134_1
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_59_1
e_1_2_10_31_1
e_1_2_10_50_1
e_1_2_10_62_1
e_1_2_10_104_1
e_1_2_10_127_1
e_1_2_10_85_1
e_1_2_10_28_1
e_1_2_10_66_1
e_1_2_10_100_1
e_1_2_10_123_1
e_1_2_10_47_1
e_1_2_10_89_1
References_xml – volume: 44
  start-page: 1055
  year: 2014
  end-page: 1068
  article-title: Ageing and the epidemiology of multimorbidity
  publication-title: Eur Respir J
– volume: 17
  start-page: 162
  year: 2018
  end-page: 173
  article-title: Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
  publication-title: Lancet Neurol
– volume: 25
  start-page: 890
  issue: 2_suppl
  year: 2019
  end-page: 938
  article-title: ECTRIMS 2019 – late breaking news abstracts
  publication-title: Mult Scler J
– volume: 10
  start-page: 113
  year: 2018
  article-title: Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
  publication-title: Alzheimer's Res Ther
– volume: 3
  start-page: 1757
  year: 1994
  end-page: 1761
  article-title: Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis
  publication-title: Hum Mol Genet
– volume: 54
  start-page: 1655
  year: 2016
  end-page: 1661
  article-title: Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
  publication-title: Clin Chem Lab Med
– volume: 28
  start-page: 2242
  year: 2019
  end-page: 2249
  article-title: Serum neurofilament light chain concentration correlates with infarct volume but not prognosis in acute ischemic stroke
  publication-title: J Stroke Cerebrovasc Dis
– volume: 71
  start-page: 1178
  year: 2018
  end-page: 1184
  article-title: Neurofilament as neuronal injury blood marker in preeclampsia
  publication-title: Hypertension
– volume: 11
  start-page: 812
  year: 2020
  article-title: Serum neurofilament light levels in normal aging and their association with morphologic brain changes
  publication-title: Nat Commun
– volume: 88
  start-page: 930
  year: 2017
  end-page: 937
  article-title: Blood‐based NfL: a biomarker for differential diagnosis of parkinsonian disorder
  publication-title: Neurology
– volume: 1
  start-page: 15056
  year: 2015
  article-title: Alzheimer's disease
  publication-title: Nat Rev Dis Primers
– volume: 9
  start-page: 54
  year: 2013
  end-page: 58
  article-title: Preclinical Alzheimer disease—the challenges ahead
  publication-title: Nat Rev Neurol
– volume: 67
  start-page: 2013
  year: 1996
  end-page: 2018
  article-title: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF
  publication-title: J. Neurochem
– volume: 26
  start-page: 1691
  year: 2019
  end-page: 1699
  article-title: Neurofilament light levels are associated with long‐term outcomes in multiple sclerosis
  publication-title: Mult Scler
– volume: 6
  start-page: 2045
  year: 2016
  end-page: 2322
  article-title: Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
  publication-title: Sci Rep
– volume: 90
  start-page: 1059
  year: 2019
  end-page: 1067
  article-title: Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta‐analysis of case–control studies
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 19
  start-page: 422
  year: 2020
  end-page: 433
  article-title: Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
  publication-title: Lancet Neurol
– volume: 383
  start-page: 109
  year: 2020
  end-page: 119
  article-title: Phase 1–2 trial of antisense oligonucleotide tofersen for ALS
  publication-title: N Engl J Med
– volume: 80
  start-page: 291
  year: 2020
  end-page: 295
  article-title: Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults
  publication-title: Scand J Clin Lab Invest
– volume: 88
  start-page: 826
  year: 2017
  end-page: 831
  article-title: Serum neurofilament is associated with progression of brain atrophy and disability in early MS
  publication-title: Neurology
– volume: 141
  start-page: 2382
  year: 2018
  end-page: 2391
  article-title: Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
  publication-title: Brain
– volume: 33
  start-page: 456
  year: 2019
  end-page: 462
  article-title: NFL blood levels are moderated by subconcussive impacts in a cohort of college football players
  publication-title: Brain Inj
– volume: 25
  start-page: 277
  year: 2019
  end-page: 283
  article-title: Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
  publication-title: Nat Med
– volume: 94
  year: 2015
  article-title: Serum phosphorylated neurofilament‐heavy chain, a potential biomarker, is associated with peripheral neuropathy in patients with type 2 diabetes
  publication-title: Medicine
– volume: 19
  start-page: 1597
  year: 2013
  end-page: 1603
  article-title: A comparative study of CSF neurofilament light and heavy chain protein in MS
  publication-title: Mult. Scler
– volume: 92
  start-page: e733
  year: 2019
  end-page: e741
  article-title: Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
  publication-title: Neurology
– volume: 3
  start-page: 17071
  year: 2017
  article-title: Amyotrophic lateral sclerosis
  publication-title: Nat Rev Dis Primers
– volume: 15
  start-page: 209
  year: 2018
  article-title: Neurofilament levels, disease activity and brain volume during follow‐up in multiple sclerosis
  publication-title: J Neuroinflammation
– start-page: 135245852091237
  year: 2020
  article-title: Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis
  publication-title: Mult Scler
– volume: 130
  start-page: 1003
  year: 2014
  end-page: 1008
  article-title: Cardiovascular physiology of pregnancy
  publication-title: Circulation
– volume: 93
  start-page: e252
  year: 2019
  end-page: e260
  article-title: Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
  publication-title: Neurology
– volume: 267
  start-page: 162
  year: 2020
  end-page: 167
  article-title: Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
  publication-title: J Neurol
– volume: 74
  start-page: 557
  year: 2017
  end-page: 566
  article-title: Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease
  publication-title: JAMA Neurol
– volume: 39
  start-page: 614
  year: 2018
  end-page: 615
  article-title: P2908Serum light‐chain neurofilament, a brain lesion marker, correlates with CHA2DS2‐VASc score among patients with atrial fibrillation: a cross‐sectional study
  publication-title: Eur Heart J
– volume: 50
  start-page: 3077
  year: 2019
  end-page: 3084
  article-title: NfL (Neurofilament Light Chain) levels as a predictive marker for long‐term outcome after ischemic stroke
  publication-title: Stroke
– volume: 77
  start-page: 58
  year: 2020
  end-page: 64
  article-title: Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis
  publication-title: JAMA Neurol
– volume: 14
  start-page: 577
  year: 2018
  end-page: 589
  article-title: Neurofilaments as biomarkers in neurological disorders
  publication-title: Nat Rev Neurol
– volume: 5
  start-page: 1478
  year: 2018
  end-page: 1491
  article-title: Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
  publication-title: Ann Clin Transl Neurol
– volume: 88
  start-page: 878
  year: 2020
  end-page: 892
  article-title: Plasma NT1 tau is a specific and early marker of Alzheimer’s disease
  publication-title: Ann Neurol
– volume: 84
  start-page: 2247
  year: 2015
  end-page: 2257
  article-title: Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis
  publication-title: Neurology
– volume: 12
  start-page: 175628641984605
  year: 2019
  article-title: Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment
  publication-title: Ther Adv Neurol Disord
– volume: 7
  start-page: 139
  year: 2020
  end-page: 143
  article-title: Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
  publication-title: Ann Clin Transl Neurol
– volume: 10
  start-page: 71
  year: 2018
  article-title: Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
  publication-title: Alzheimer's Res Ther
– volume: 3
  start-page: 623
  year: 2016
  end-page: 636
  article-title: Neurofilament light chain: a biomarker for genetic frontotemporal dementia
  publication-title: Ann Clin Transl Neurol
– volume: 95
  start-page: e59
  year: 2020
  end-page: e69
  article-title: CReATe Consortium. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
  publication-title: Neurology
– volume: 4
  year: 2018
  article-title: Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics
  publication-title: BMJ Open Sport Exerc Med
– volume: 57
  start-page: 1556
  year: 2019
  end-page: 1564
  article-title: Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
  publication-title: Clin Chem Lab Med
– volume: 24
  start-page: 121
  issue: 2_suppl
  year: 2018
  end-page: 327
  article-title: ECTRIMS 2018 ‐ poster session 1
  publication-title: Mult Scler
– volume: 92
  start-page: e1479
  year: 2019
  end-page: e1486
  article-title: Serum NFL discriminates Parkinson disease from atypical parkinsonisms
  publication-title: Neurology
– volume: 5
  start-page: 70
  year: 2019
  article-title: Ischaemic stroke
  publication-title: Nat Rev Dis Primers
– volume: 90
  start-page: e1780
  year: 2018
  end-page: e1788
  article-title: Neurofilament light and tau as blood biomarkers for sports‐related concussion
  publication-title: Neurology
– volume: 339
  start-page: 285
  year: 1998
  end-page: 291
  article-title: Rate of pregnancy‐related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group
  publication-title: N Engl J Med
– volume: 25
  start-page: 562
  year: 2018
  end-page: 568
  article-title: Serum neurofilament light chain in patients with acute cerebrovascular events
  publication-title: Eur J Neurol
– volume: 9
  start-page: 180
  year: 2019
  article-title: Plasma neurofilament light chain concentration is increased in anorexia nervosa
  publication-title: Transl Psychiatry
– volume: 6
  start-page: 1664
  year: 2015
  end-page: 2295
  article-title: A practical guide to immunoassay method validation
  publication-title: Front Neuro
– volume: 5
  start-page: e422
  year: 2018
  article-title: Neurofilament light chain predicts disease activity in relapsing‐remitting MS
  publication-title: Neurol Neuroimmunol Neuroinflamm
– volume: 58
  start-page: 14
  year: 2017
  end-page: 29
  article-title: Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer’s disease
  publication-title: Neurobiol Aging
– volume: 18
  start-page: 1103
  year: 2019
  end-page: 1111
  article-title: Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
  publication-title: Lancet Neurol
– volume: 90
  start-page: S8.006
  issue: 15 Supplement
  year: 2018
  article-title: Siponimod reduces neurofilament light chain blood levels in secondary progressive multiple sclerosis patients (S8.006)
  publication-title: Neurology
– volume: 91
  start-page: e1390
  year: 2018
  end-page: e1401
  article-title: Serum neurofilament light chain in behavioral variant frontotemporal dementia
  publication-title: Neurology
– volume: 21
  start-page: 53
  year: 2002
  end-page: 59
  article-title: Monoclonal antibodies selective for low molecular weight neurofilaments
  publication-title: Hybrid Hybridomics
– volume: 62
  start-page: 865
  year: 2005
  end-page: 870
  article-title: Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement
  publication-title: Arch Neurol
– volume: 76
  start-page: 1035
  year: 2019
  end-page: 1048
  article-title: Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta‐analysis
  publication-title: JAMA Neurol
– volume: 94
  start-page: e2457
  year: 2020
  end-page: e2467
  article-title: Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis
  publication-title: Neurology
– volume: 84
  start-page: 130
  year: 2018
  end-page: 139
  article-title: Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion
  publication-title: Ann Neurol
– volume: 89
  start-page: 2230
  year: 2017
  end-page: 2237
  article-title: Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
  publication-title: Neurology
– volume: 19
  start-page: 513
  year: 2020
  end-page: 521
  article-title: Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer’s disease kindred: a cross‐sectional and longitudinal cohort study
  publication-title: Lancet Neurol
– volume: 8
  year: 2013
  article-title: Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
  publication-title: PLoS One
– volume: 7
  start-page: 945
  year: 2020
  end-page: 955
  article-title: Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis
  publication-title: Ann Clin Transl Neurol
– volume: 143
  start-page: 1975
  year: 2020
  end-page: 1998
  article-title: Neurofilaments: neurobiological foundations for biomarker applications
  publication-title: Brain
– volume: 2
  start-page: 16084
  year: 2016
  article-title: Traumatic brain injuries
  publication-title: Nat Rev Dis Primers
– volume: 25
  start-page: 678
  year: 2019
  end-page: 686
  article-title: Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
  publication-title: Mult Scler
– volume: 94
  start-page: e1201
  year: 2020
  end-page: e1212
  article-title: Blood neurofilament light levels segregate treatment effects in multiple sclerosis
  publication-title: Neurology
– volume: 7
  start-page: e749
  year: 2020
  article-title: Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
  publication-title: Neurol Neuroimmunol Neuroinflamm
– volume: 27
  start-page: 647
  year: 2013
  end-page: 661
  article-title: Heterophilic antibody interference in immunometric assays
  publication-title: Best Pract Res Clin Endocrinol Metab
– volume: 24
  start-page: 530
  issue: 2_suppl
  year: 2018
  end-page: 737
  article-title: ECTRIMS 2018 ‐ poster session 3
  publication-title: Mult Scler
– volume: 8
  start-page: 17368
  year: 2018
  article-title: Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
  publication-title: Sci Rep
– volume: 27
  start-page: 251
  year: 2020
  end-page: 257
  article-title: Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis
  publication-title: Eur J Neurol
– volume: 92
  start-page: e1007
  year: 2019
  end-page: e1015
  article-title: Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
  publication-title: Neurology
– volume: 87
  start-page: 3
  year: 2016
  end-page: 4
  article-title: Are neurofilaments heading for the ALS clinic?
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 62
  start-page: 1125
  year: 2018
  end-page: 1140
  article-title: The past and the future of Alzheimer’s disease fluid biomarkers1
  publication-title: JAD
– volume: 87
  start-page: 1329
  year: 2016
  end-page: 1336
  article-title: Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
  publication-title: Neurology
– volume: 94
  start-page: e1950
  issue: 18
  year: 2020
  end-page: e1960
  article-title: Vitamin D, smoking, EBV, and long‐term cognitive performance in MS: 11‐year follow‐up of BENEFIT
  publication-title: Neurology
– volume: 11
  start-page: 19
  year: 2019
  article-title: Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
  publication-title: Alzheimer's Res Ther
– volume: 15
  start-page: 681
  year: 1994
  end-page: 690
  article-title: Gene expression in Alzheimer neocortex as a function of age and pathologic severity
  publication-title: Neurobiol Aging
– volume: 24
  start-page: 187
  year: 2019
  end-page: 194
  article-title: Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
  publication-title: J Peripher Nerv Syst
– volume: 19
  start-page: 403
  year: 2019
  article-title: Impact of parturition on maternal cardiovascular and neuronal integrity in a high risk cohort – a prospective cohort study
  publication-title: BMC Pregnancy Childbirth
– volume: 7
  start-page: 5
  year: 2019
  article-title: Increased plasma neurofilament light chain concentration correlates with severity of post‐mortem neurofibrillary tangle pathology and neurodegeneration
  publication-title: Acta Neuropathol Commun
– volume: 35
  start-page: 2351
  year: 2018
  end-page: 2356
  article-title: Longitudinal performance of plasma neurofilament light and tau in professional fighters: the professional fighters brain health study
  publication-title: J Neurotrauma
– volume: 267
  start-page: 36
  year: 2020
  end-page: 44
  article-title: Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen
  publication-title: J Neurol
– volume: 2
  start-page: 452
  year: 2020
  end-page: 458
  article-title: A multi‐center study of neurofilament assay reliability and inter‐laboratory variability
  publication-title: Amyotroph Lateral Scler Frontotemporal Degener
– volume: 9
  start-page: a018309
  issue: 4
  year: 2017
  article-title: Neurofilaments and neurofilament proteins in health and disease
  publication-title: Cold Spring Harb Perspect Biol
– volume: 1668
  start-page: 12
  year: 2017
  end-page: 19
  article-title: Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood‐brain barrier permeability
  publication-title: Brain Res
– volume: 6
  start-page: 46
  year: 2019
  end-page: 56
  article-title: Serum Neurofilament light correlates with CADASIL disease severity and survival
  publication-title: Ann Clin Transl Neurol
– volume: 77
  start-page: 1093
  year: 2018
  end-page: 1094
  article-title: Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy
  publication-title: Ann Rheum Dis
– volume: 59
  start-page: 972
  year: 2000
  end-page: 982
  article-title: Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic Amyotrophic Lateral Sclerosis (ALS)
  publication-title: J Neuropathol Exp Neurol
– volume: 88
  start-page: 1788
  year: 2017
  end-page: 1794
  article-title: Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
  publication-title: Neurology
– volume: 74
  start-page: 43
  year: 2020
  end-page: 49
  article-title: Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson’s disease
  publication-title: Parkinsonism Relat Disord
– volume: 88
  start-page: 2302
  year: 2017
  end-page: 2309
  article-title: Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease
  publication-title: Neurology
– volume: 77
  start-page: 1008
  year: 2020
  end-page: 1017
  article-title: Use of multimodal imaging and clinical biomarkers in presymptomatic carriers of C9orf72 repeat expansion
  publication-title: JAMA Neurol
– volume: 7
  start-page: 1661
  year: 2020
  end-page: 1673
  article-title: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
  publication-title: Ann Clin Transl Neurol
– volume: 10
  start-page: 448
  year: 2018
  end-page: 451
  article-title: Stability of blood‐based biomarkers of Alzheimer’s disease over multiple freeze‐thaw cycles
  publication-title: Alzheimer’s Dement
– volume: 266
  start-page: 2796
  year: 2019
  end-page: 2806
  article-title: Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction
  publication-title: J Neurol
– volume: 21
  start-page: 533
  year: 2016
  end-page: 547
  article-title: The simoa HD‐1 analyzer: A novel fully automated digital immunoassay analyzer with single‐molecule sensitivity and multiplexing
  publication-title: J Lab Autom
– volume: 3
  start-page: 313
  year: 2013
  end-page: 320
  article-title: Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997–2011
  publication-title: Neurology
– volume: 93
  start-page: e968
  year: 2019
  end-page: e974
  article-title: Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes
  publication-title: Neurology
– volume: 81
  start-page: 857
  year: 2017
  end-page: 870
  article-title: Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis
  publication-title: Ann Neurol
– volume: 79
  start-page: 152
  year: 2016
  end-page: 158
  article-title: Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
  publication-title: Ann Neurol
– volume: 7
  start-page: e714
  year: 2020
  article-title: Monitoring of radiologic disease activity by serum neurofilaments in MS
  publication-title: Neurol Neuroimmunol Neuroinflamm
– volume: 45
  start-page: 291
  year: 2019
  end-page: 304
  article-title: Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
  publication-title: Neuropathol Appl Neurobiol
– volume: 122
  start-page: 189
  year: 1994
  end-page: 203
  article-title: Flow rate of cerebrospinal fluid (CSF)–a concept common to normal blood‐CSF barrier function and to dysfunction in neurological diseases
  publication-title: J Neurol Sci
– volume: 90
  start-page: e22
  year: 2018
  end-page: e30
  article-title: Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
  publication-title: Neurology
– volume: 90
  start-page: 157
  year: 2019
  end-page: 164
  article-title: Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 386
  start-page: 1672
  year: 2015
  end-page: 1682
  article-title: Frontotemporal dementia
  publication-title: The Lancet
– volume: 113
  start-page: 137
  year: 2019
  end-page: 140
  article-title: Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia
  publication-title: J Psychiatr Res
– volume: 6
  start-page: 1757
  year: 2019
  end-page: 1770
  article-title: Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
  publication-title: Ann Clin Transl Neurol
– volume: 16
  start-page: 601
  year: 2017
  end-page: 609
  article-title: Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington’s disease: a retrospective cohort analysis
  publication-title: Lancet Neurol
– volume: 86
  start-page: 1446
  year: 2016
  end-page: 1453
  article-title: Recommendations for observational studies of comorbidity in multiple sclerosis
  publication-title: Neurology
– volume: 3
  start-page: 135
  year: 2016
  end-page: 140
  article-title: Plasma concentration of the Neurofilament Light Protein (NFL) is a biomarker of CNS injury in HIV infection: a cross‐sectional study
  publication-title: EBioMedicine
– volume: 20
  start-page: 538
  issue: 7–8
  year: 2019
  end-page: 548
  article-title: Neurofilaments in pre‐symptomatic ALS and the impact of genotype
  publication-title: Amyotroph Lateral Scler Frontotemporal Degener
– volume: 35
  start-page: 288
  year: 2020
  end-page: 295
  article-title: CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson’s from controls
  publication-title: Mov Disord
– volume: 25
  start-page: 581
  issue: 2_suppl
  year: 2019
  end-page: 805
  article-title: ECTRIMS 2019 ‐ poster session 3
  publication-title: Mult Scler
– volume: 89
  start-page: 2108
  year: 2017
  end-page: 2114
  article-title: Serum neurofilament light is sensitive to active cerebral small vessel disease
  publication-title: Neurology
– volume: 76
  start-page: 1359
  year: 2019
  end-page: 1366
  article-title: Association between serum neurofilament light chain levels and long‐term disease course among patients with multiple sclerosis followed up for 12 years
  publication-title: JAMA Neurol
– volume: 24
  start-page: 1046
  year: 2018
  end-page: 1054
  article-title: Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
  publication-title: Mult Scler
– volume: 14
  start-page: 133
  year: 2018
  end-page: 150
  article-title: Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
  publication-title: Nat Rev Neurol
– volume: 6
  start-page: 1081
  year: 2019
  end-page: 1089
  article-title: Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
  publication-title: Ann Clin Transl Neurol
– volume: 20
  start-page: 228
  year: 2018
  end-page: 238
  article-title: Serum neurofilament light chain levels are related to small vessel disease burden
  publication-title: J Stroke
– volume: 89
  start-page: 367
  year: 2018
  end-page: 373
  article-title: Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 146
  start-page: 631
  year: 2018
  end-page: 641
  article-title: A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry
  publication-title: J Neurochem
– volume: 26
  start-page: 1200
  year: 2019
  end-page: 1204
  article-title: Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study
  publication-title: Eur J Neurol
– volume: 91
  start-page: e1338
  year: 2018
  end-page: e1347
  article-title: Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke
  publication-title: Neurology
– volume: 90
  start-page: 1324
  year: 2019
  end-page: 1330
  article-title: Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 50
  start-page: 1669
  year: 2019
  end-page: 1675
  article-title: Serum NfL (Neurofilament Light Chain) levels and incident stroke in adults with diabetes mellitus
  publication-title: Stroke
– volume: 33
  start-page: 1784
  year: 2016
  end-page: 1789
  article-title: Serum neurofilament light in american football athletes over the course of a season
  publication-title: J Neurotrauma
– volume: 56
  start-page: 102807
  year: 2020
  article-title: Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study
  publication-title: EBioMedicine
– volume: 90
  start-page: e518
  year: 2018
  end-page: e524
  article-title: Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
  publication-title: Neurology
– volume: 89
  start-page: 2167
  year: 2017
  end-page: 2175
  article-title: Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration
  publication-title: Neurology
– volume: 3
  start-page: 17013
  year: 2017
  article-title: Parkinson disease
  publication-title: Nat Rev Dis Primers
– ident: e_1_2_10_3_1
  doi: 10.1136/annrheumdis-2017-212045
– ident: e_1_2_10_31_1
  doi: 10.1016/j.dadm.2018.06.001
– ident: e_1_2_10_136_1
  doi: 10.1212/WNL.0000000000003154
– ident: e_1_2_10_83_1
  doi: 10.1002/acn3.795
– ident: e_1_2_10_118_1
  doi: 10.5853/jos.2017.02565
– ident: e_1_2_10_39_1
  doi: 10.1016/0022-510X(94)90298-4
– ident: e_1_2_10_132_1
  doi: 10.1007/s00415-019-09567-8
– ident: e_1_2_10_122_1
  doi: 10.1007/s00415-019-09477-9
– ident: e_1_2_10_105_1
  doi: 10.1101/cshperspect.a018309
– volume: 24
  start-page: 121
  issue: 2
  year: 2018
  ident: e_1_2_10_36_1
  article-title: ECTRIMS 2018 ‐ poster session 1
  publication-title: Mult Scler
– ident: e_1_2_10_47_1
  doi: 10.1212/WNL.0000000000007179
– ident: e_1_2_10_52_1
  doi: 10.1212/WNL.0000000000002474
– ident: e_1_2_10_34_1
  doi: 10.1212/WNL.0000000000009097
– ident: e_1_2_10_51_1
  doi: 10.1183/09031936.00059814
– ident: e_1_2_10_11_1
  doi: 10.1016/j.beem.2013.05.011
– ident: e_1_2_10_8_1
  doi: 10.1016/0197-4580(94)90049-3
– ident: e_1_2_10_42_1
  doi: 10.1177/1352458520912379
– ident: e_1_2_10_21_1
  doi: 10.1212/WNL.0000000000003912
– ident: e_1_2_10_137_1
  doi: 10.1212/WNL.0000000000009371
– ident: e_1_2_10_119_1
  doi: 10.1002/acn3.678
– ident: e_1_2_10_126_1
  doi: 10.1136/bmjsem-2018-000433
– ident: e_1_2_10_76_1
  doi: 10.1212/NXI.0000000000000749
– volume: 24
  start-page: 530
  issue: 2
  year: 2018
  ident: e_1_2_10_35_1
  article-title: ECTRIMS 2018 ‐ poster session 3
  publication-title: Mult Scler
– ident: e_1_2_10_4_1
  doi: 10.1111/jns.12319
– ident: e_1_2_10_49_1
  doi: 10.1111/nan.12511
– ident: e_1_2_10_112_1
  doi: 10.1111/jnc.14542
– ident: e_1_2_10_33_1
  doi: 10.1002/ana.24954
– ident: e_1_2_10_59_1
  doi: 10.1002/acn3.50972
– ident: e_1_2_10_103_1
  doi: 10.1080/21678421.2019.1646769
– ident: e_1_2_10_78_1
  doi: 10.1056/NEJM199807303390501
– ident: e_1_2_10_70_1
  doi: 10.1001/jamaneurol.2019.2137
– ident: e_1_2_10_19_1
  doi: 10.1212/WNL.0000000000007032
– ident: e_1_2_10_97_1
  doi: 10.1016/S1474-4422(20)30137-X
– ident: e_1_2_10_87_1
  doi: 10.1016/S1474-4422(20)30071-5
– ident: e_1_2_10_92_1
  doi: 10.1186/s40478-018-0649-3
– ident: e_1_2_10_100_1
  doi: 10.1212/WNL.0000000000004761
– ident: e_1_2_10_107_1
  doi: 10.1136/jnnp-2017-316605
– ident: e_1_2_10_61_1
  doi: 10.1161/CIRCULATIONAHA.114.009029
– ident: e_1_2_10_66_1
  doi: 10.1212/WNL.0000000000006902
– ident: e_1_2_10_16_1
  doi: 10.1038/s41591-018-0304-3
– ident: e_1_2_10_94_1
  doi: 10.1212/WNL.0000000000007767
– ident: e_1_2_10_91_1
  doi: 10.1186/s13195-018-0439-y
– ident: e_1_2_10_68_1
  doi: 10.1136/jnnp-2018-319190
– volume: 90
  start-page: S8.006
  issue: 15
  year: 2018
  ident: e_1_2_10_81_1
  article-title: Siponimod reduces neurofilament light chain blood levels in secondary progressive multiple sclerosis patients (S8.006)
  publication-title: Neurology
  doi: 10.1212/WNL.90.15_supplement.S8.006
– ident: e_1_2_10_55_1
  doi: 10.1001/jamaneurol.2019.1534
– ident: e_1_2_10_82_1
  doi: 10.1212/NXI.0000000000000714
– ident: e_1_2_10_128_1
  doi: 10.1089/neu.2017.5553
– ident: e_1_2_10_127_1
  doi: 10.1212/WNL.0000000000005518
– ident: e_1_2_10_110_1
  doi: 10.1001/jamaneurol.2020.1087
– ident: e_1_2_10_10_1
  doi: 10.1089/15368590252917647
– ident: e_1_2_10_65_1
  doi: 10.1212/WNL.0000000000003653
– ident: e_1_2_10_99_1
  doi: 10.1038/nrdp.2017.71
– ident: e_1_2_10_116_1
  doi: 10.1016/j.parkreldis.2020.04.009
– ident: e_1_2_10_14_1
  doi: 10.1016/j.ebiom.2015.11.036
– ident: e_1_2_10_2_1
  doi: 10.1038/s41582-018-0058-z
– ident: e_1_2_10_29_1
  doi: 10.1177/1352458513482374
– ident: e_1_2_10_46_1
  doi: 10.1212/WNL.0000000000003680
– ident: e_1_2_10_93_1
  doi: 10.1038/s41598-018-35766-w
– ident: e_1_2_10_129_1
  doi: 10.1038/srep36791
– ident: e_1_2_10_84_1
  doi: 10.1038/nrdp.2015.56
– ident: e_1_2_10_117_1
  doi: 10.1038/s41572-019-0118-8
– ident: e_1_2_10_25_1
  doi: 10.1080/21678421.2020.1779300
– ident: e_1_2_10_23_1
  doi: 10.1212/WNL.0000000000006282
– ident: e_1_2_10_53_1
  doi: 10.1111/ene.14063
– ident: e_1_2_10_114_1
  doi: 10.1038/nrdp.2017.13
– ident: e_1_2_10_28_1
  doi: 10.1080/00365513.2020.1730434
– ident: e_1_2_10_120_1
  doi: 10.1016/j.jstrokecerebrovasdis.2019.05.008
– ident: e_1_2_10_98_1
  doi: 10.1002/acn3.51158
– ident: e_1_2_10_37_1
  doi: 10.1177/1352458519868081
– ident: e_1_2_10_56_1
  doi: 10.1161/STROKEAHA.119.024941
– ident: e_1_2_10_86_1
  doi: 10.1002/ana.25885
– ident: e_1_2_10_96_1
  doi: 10.1186/s13195-019-0472-5
– ident: e_1_2_10_108_1
  doi: 10.1212/WNL.0000000000004029
– ident: e_1_2_10_40_1
  doi: 10.1001/archneur.62.6.865
– ident: e_1_2_10_13_1
  doi: 10.1371/journal.pone.0075091
– ident: e_1_2_10_79_1
  doi: 10.1177/1352458519885613
– ident: e_1_2_10_88_1
  doi: 10.1038/nrneurol.2012.241
– ident: e_1_2_10_6_1
  doi: 10.1046/j.1471-4159.1996.67052013.x
– ident: e_1_2_10_5_1
  doi: 10.1212/WNL.0000000000004932
– ident: e_1_2_10_109_1
  doi: 10.1212/WNL.0000000000009559
– volume: 3
  start-page: 313
  year: 2013
  ident: e_1_2_10_54_1
  article-title: Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997–2011
  publication-title: Neurology
– ident: e_1_2_10_131_1
  doi: 10.1016/j.jpsychires.2019.03.019
– ident: e_1_2_10_15_1
  doi: 10.1177/2211068215589580
– ident: e_1_2_10_130_1
  doi: 10.1016/S0140-6736(15)00461-4
– ident: e_1_2_10_101_1
  doi: 10.1002/ana.24552
– ident: e_1_2_10_140_1
  doi: 10.1016/S1474-4422(17)30124-2
– ident: e_1_2_10_72_1
  doi: 10.1016/j.ebiom.2020.102807
– ident: e_1_2_10_111_1
  doi: 10.1056/NEJMoa2003715
– ident: e_1_2_10_89_1
  doi: 10.1016/j.neurobiolaging.2017.06.002
– ident: e_1_2_10_22_1
  doi: 10.1212/WNL.0000000000004645
– ident: e_1_2_10_24_1
  doi: 10.1515/cclm-2019-0015
– volume: 87
  start-page: 3
  year: 2016
  ident: e_1_2_10_106_1
  article-title: Are neurofilaments heading for the ALS clinic?
  publication-title: J Neurol Neurosurg Psychiatry
– ident: e_1_2_10_9_1
  doi: 10.1093/brain/awaa098
– ident: e_1_2_10_74_1
  doi: 10.1212/WNL.0000000000009571
– ident: e_1_2_10_133_1
  doi: 10.1016/S1474-4422(19)30354-0
– ident: e_1_2_10_113_1
  doi: 10.1093/hmg/3.10.1757
– ident: e_1_2_10_104_1
  doi: 10.1136/jnnp-2018-318704
– volume: 90
  start-page: 1324
  year: 2019
  ident: e_1_2_10_27_1
  article-title: Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients
  publication-title: J Neurol Neurosurg Psychiatry
– ident: e_1_2_10_85_1
  doi: 10.3233/JAD-170773
– ident: e_1_2_10_121_1
  doi: 10.1111/ene.13554
– ident: e_1_2_10_12_1
  doi: 10.1515/cclm-2015-1195
– ident: e_1_2_10_124_1
  doi: 10.1089/neu.2015.4295
– ident: e_1_2_10_102_1
  doi: 10.1002/ana.25276
– ident: e_1_2_10_69_1
  doi: 10.1001/jamaneurol.2019.3238
– ident: e_1_2_10_134_1
  doi: 10.1002/acn3.325
– ident: e_1_2_10_60_1
  doi: 10.1038/s41398-019-0518-2
– ident: e_1_2_10_73_1
  doi: 10.1177/1352458518765666
– ident: e_1_2_10_18_1
  doi: 10.1161/STROKEAHA.119.026410
– ident: e_1_2_10_43_1
  doi: 10.1212/WNL.0000000000004683
– ident: e_1_2_10_125_1
  doi: 10.1080/02699052.2019.1565895
– ident: e_1_2_10_75_1
  doi: 10.1212/WNL.0000000000008057
– ident: e_1_2_10_115_1
  doi: 10.1002/mds.27897
– ident: e_1_2_10_64_1
  doi: 10.1016/S1474-4422(17)30470-2
– ident: e_1_2_10_67_1
  doi: 10.1002/acn3.50872
– ident: e_1_2_10_63_1
  doi: 10.1111/ene.13965
– ident: e_1_2_10_77_1
  doi: 10.1212/NXI.0000000000000422
– ident: e_1_2_10_71_1
  doi: 10.1002/acn3.638
– ident: e_1_2_10_135_1
  doi: 10.1212/WNL.0000000000006318
– ident: e_1_2_10_7_1
  doi: 10.1093/jnen/59.11.972
– ident: e_1_2_10_41_1
  doi: 10.1016/j.brainres.2017.05.011
– ident: e_1_2_10_30_1
  doi: 10.1186/s13195-018-0404-9
– ident: e_1_2_10_95_1
  doi: 10.1212/WNL.0000000000004667
– ident: e_1_2_10_62_1
  doi: 10.1161/HYPERTENSIONAHA.117.10314
– ident: e_1_2_10_50_1
  doi: 10.1038/s41467-020-14612-6
– ident: e_1_2_10_138_1
  doi: 10.1186/s12884-019-2570-6
– ident: e_1_2_10_57_1
  doi: 10.1093/eurheartj/ehy565.P2908
– ident: e_1_2_10_17_1
  doi: 10.1093/brain/awy154
– ident: e_1_2_10_38_1
  doi: 10.1038/nrneurol.2017.188
– ident: e_1_2_10_58_1
  doi: 10.1097/MD.0000000000001908
– ident: e_1_2_10_90_1
  doi: 10.1001/jamaneurol.2016.6117
– ident: e_1_2_10_45_1
  doi: 10.1186/s12974-018-1249-7
– ident: e_1_2_10_44_1
  doi: 10.1007/s00415-019-09547-y
– ident: e_1_2_10_20_1
  doi: 10.1002/acn3.51060
– ident: e_1_2_10_80_1
  doi: 10.1177/1352458519869496
– ident: e_1_2_10_139_1
  doi: 10.1177/1756286419846058
– ident: e_1_2_10_48_1
  doi: 10.1212/WNL.0000000000001642
– ident: e_1_2_10_26_1
  doi: 10.1177/1352458517715132
– ident: e_1_2_10_32_1
  doi: 10.3389/fneur.2015.00179
– ident: e_1_2_10_123_1
  doi: 10.1038/nrdp.2016.84
SSID ssj0001125372
Score 2.5575542
SecondaryResourceType review_article
Snippet Neuronal injury is a universal event that occurs in disease processes that affect both the central and peripheral nervous systems. A blood biomarker linked to...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2508
SubjectTerms Antibodies
Biomarkers
Blood
Brain research
Disease
Gene expression
Nervous system
Neurological disorders
Physiology
Plasma
Review
Reviews
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT-QwDLZYWK24ALvLo7wUBBeQukzrtJlwQYBAXHbEAaS5VUnaaEdCLTADvx8nzRRGrLhwi5Q0TWPH_hy7NsCBM3S0slksexXGXFkba8xlnPcwQ664RN33xSbEYNAfDuVNuHAbh7DKqUz0grpsjLsjP07JjuOC9KM8fXiMXdUo510NJTS-wYIrm-34XAzF2x0LaW8UaZeVND1WpsY_pOOQz-qhD-DyY4zke-zqlc_V8leXvQJLAXays5ZPfsJcVf-CH3-DY_033J27AHbms1vaEXEJrYfdO8P9hClmQj0E1v7owhrLRpMxe-f8ZpOmfdiLUhbcPqtwd3V5e3Edh4oLsSHgxGOlSuwLzRNXfYOnVhpqVWlJmEBkic3LJFeJlWiTniSsoJUgWWlSXeZolREK12C-bupqA5hGNJkubUYzcp0ric6SJGtLEATJVD-Cw-n-FyakI3dVMe6LNpFyWjhaFZ5WEex3Yx_aJBz_HbU9JUERDuK4eNv_CPa6bjpCzi-i6qp5dmPI6BKElHsRrLdU716DSKpEZjS5mOGHboBLzz3bU4_--TTdQpCw5BjBkeecT1ZenF0M0Lc2P_-GLVhMnb3vw2m2YX7y9FztwHfzMhmNn3Y9878Ce2sNSQ
  priority: 102
  providerName: ProQuest
Title Blood neurofilament light: a critical review of its application to neurologic disease
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Facn3.51234
https://www.ncbi.nlm.nih.gov/pubmed/33146954
https://www.proquest.com/docview/2469476639
https://www.proquest.com/docview/2457679990
https://pubmed.ncbi.nlm.nih.gov/PMC7732243
Volume 7
WOSCitedRecordID wos000584729800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: 7X7
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: BENPR
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: M2M
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: PIMPY
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: WIN
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2328-9503
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001125372
  issn: 2328-9503
  databaseCode: 24P
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFiEuvB-BsjKCC0ihiceJY8SlrVrRw0YRomI5RbYTi5WqLOpu-f2MnWy2qyIkxMXKY-IkzoznG9v5BuCtD3SMdlmskhZjoZ2LDeYqzhPMUGih0BQh2YQsy2I2U9UOfFr_C9PzQ4wDbt4yQn_tDVyb5cGGNFTbDj-Qu0JxC_bSFKXXaS6qzQgL-W4M2ZsINZBVZwmO_KT8YHP5tke6ATNvrpa8jmKDGzq9_38v8ADuDfCTHfb68hB22u4R3JkOE-yP4fzIL2RngeXSzUlb6GnYhQ_gPzLN7JAXgfU_vLCFY_PVkl2bBGerRX9x6FLZMP3zBM5PT74ef46HzAuxJQAlYq0bLKQRqc_CIbhTlrZa3hA2kFnq8ibNdeoUujRRhBmMltRnWm6aHJ22UuNT2O0WXfscmEG0mWlcRjUKk2uFPqKkqEsSFMl0EcG7devXdqAl99kxLuqeUJnXvp3q0E4RvBllf_ZkHH-U2l9_xHowyGXNRa6EJHilIng9niZT8vMjumsXV16Ggi9JiDmJ4Fn_zcfbIJJLURlVLre0YRTwNN3bZ7r5j0DXLSV1mgIjeB-04S9PXh8elxi2XvyL8Eu4y_0oQFhksw-7q8ur9hXctr9W8-XlJBgFlXImQ1lMYO_opKy-TML4A5VTPqVj1dm0-k57387K34OOFNU
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLQIuPAsEChgBByqFbjxOvEZCqBSqrtpd7aGVyik4TixWqpK2uy3iT_EbGTuPdlXUWw_cLHnixJnxfDP2eAbgrXN0Mm3jUPULDIW2NswwUWHSxxiFFgqzgS82IcfjwcGBmizBn_YujAurbHWiV9R5Zdwe-TonP05Iwkf1-eg4dFWj3OlqW0KjFoud4vcvctlmn4Zfib_vON_6tre5HTZVBUJDxoEItc5xIDMRuQoTgltlqFXwnHBPxpFN8ijRkVVoo74iPMy0JH1geJYnaLWRGmncG7AsnLD3YHkyHE2-n-_qkL2Aknd5UPm6NiV-IFRFsYh8l8zZy1GZF61lD3db9_63H3Uf7jaGNduoV8IDWCrKh3Br1IQOPIL9Ly5En_n8nXZK64Dmzw7d1sRHpplpKj6w-ioPqyybzmfswvE-m1f1wx4sWHOwtQL71zKpx9Arq7J4CixDNHGW25hGFFmiFTpfmfxJSUZWrAcBvG_5nZom4bqr-3GY1qmieepkI_WyEcCbjvaoTjPyT6rVluVpo2pm6Tm_A3jddZOScCc_uiyqU0dDbqUkX6AfwJNayrrXIBJYqpgGlwvy1xG4BOSLPeX0p09ELiXBgcAA1rykXvHl6cbmGH3r2dVzeAW3t_dGu-nucLzzHO5wt7vhg4dWoTc_OS1ewE1zNp_OTl42S4_Bj-sW4r-vmmlz
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLaq48C6EFjACDiCF3XiceI2EUGlZsSpd7YFK5ZQ6TixWqpLS3YL61_h1jJ1HuyrqrQdukTxxYns838x4PAPwyhk6mbZxqAYFhkJbG2aYqDAZYIxCC4XZ0BebkJPJ8OBATVfgT3sXxoVVtjLRC-q8Ms5H3udkxwlJ-Kj6tgmLmO6MPh7_DF0FKXfS2pbTqFlktzj7Tebb_MN4h9b6Neejz9-2v4RNhYHQkKIgQq1zHMpMRK7ahOBWGXoqeE4YKOPIJnmU6MgqtNFAETZmWpJsMDzLE7TaSI3U7w1YpfEK3oPV6Xhv-v3cw0O6A0re5UTlfW1KfEcIi2IZBS-ptpcjNC9qzh76Rnf-50m7C7cbhZtt1TvkHqwU5X1Y22tCCh7A_icXus98Xk87o_1Bc8GOnMviPdPMNJUgWH3Fh1WWzRZzduHYny2q-mUPIqw58HoI-9cyqHXolVVZPAaWIZo4y21MPYos0QqdDU12piTlK9bDAN60a5-aJhG7qwdylNYppHnq-CT1fBLAy472uE4_8k-qzXb500YEzdPztQ_gRddMwsOdCOmyqE4dDZmbkmyEQQCPao7rPoNIIKpi6lwu8WJH4BKTL7eUsx8-QbmUBBMCA3jrufaKP0-3tifon55cPYbnsEacm34dT3Y34BZ3Tg8fU7QJvcXJafEUbppfi9n85FmzCxkcXjcP_wVEFHIz
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+neurofilament+light%3A+a+critical+review+of+its+application+to+neurologic+disease&rft.jtitle=Annals+of+clinical+and+translational+neurology&rft.au=Barro%2C+Christian&rft.au=Chitnis%2C+Tanuja&rft.au=Weiner%2C+Howard+L.&rft.date=2020-12-01&rft.issn=2328-9503&rft.eissn=2328-9503&rft.volume=7&rft.issue=12&rft.spage=2508&rft.epage=2523&rft_id=info:doi/10.1002%2Facn3.51234&rft.externalDBID=10.1002%252Facn3.51234&rft.externalDocID=ACN351234
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2328-9503&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2328-9503&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2328-9503&client=summon